DWAS Among Small Cap ETFs
End-of-day Nov 16, 2026 · 68 Small cap ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.6% | −4.5% | +0.2% | −13.4% | +4.6% | +12.0% | +45.5% | +4.7% | +328.1% |
| Peer average | −1.2% | −2.1% | +1.3% | −5.3% | +14.8% | +18.8% | +63.0% | +27.5% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$20 of every $1,000 in DWAS is Replimune
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | REPLReplimune Group | Healthcare | 2.00% | $199.75 | 352K | $7.7M |
| 2 | AMRXAmneal Pharmaceuticals | Healthcare | 1.76% | $175.51 | 316K | $6.8M |
| 3 | ANROAlto Neuroscience | Healthcare | 1.68% | $168.35 | 220K | $6.5M |
| 4 | ORKAOruka Therapeutics | Healthcare | 1.64% | $164.08 | 60K | $6.3M |
| 5 | AAMIAcadian Asset Management | Financial Services | 1.49% | $149.15 | 61K | $5.8M |
| 6 | VCTRVictory Capital | Financial Services | 1.45% | $145.11 | 45K | $5.6M |
| 7 | ADPTAdaptive Biotechnologies | Healthcare | 1.39% | $139.43 | 185K | $5.4M |
| 8 | XMTRXometry | Industrials | 1.25% | $124.67 | 40K | $4.8M |
| 9 | FEIMFrequency Electronics | Technology | 1.24% | $123.68 | 75K | $4.8M |
| 10 | NBNNortheast Bank | Financial Services | 1.03% | $102.95 | 31K | $4.0M |
| 11 | INBXInhibrx Biosciences | Healthcare | 0.97% | $97.40 | 45K | $3.8M |
| 12 | AEHRAEHR Test Systems | Technology | 0.97% | $97.26 | 66K | $3.7M |
| 13 | DXPEDXP Enterprises /TX | Industrials | 0.96% | $95.56 | 24K | $3.7M |
| 14 | PRMPerimeter Group | Basic Materials | 0.95% | $95.37 | 125K | $3.7M |
| 15 | RLAYRelay Therapeutics | Healthcare | 0.94% | $94.31 | 201K | $3.6M |
of the $579B in 112 Small cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | REPL | Replimune Group | 2.00% |
| 2 | AMRX | Amneal Pharmaceuticals | 1.76% |
| 3 | ANRO | Alto Neuroscience | 1.68% |
| 4 | ORKA | Oruka Therapeutics | 1.64% |
| 5 | AAMI | Acadian Asset Management | 1.49% |
| 6 | VCTR | Victory Capital | 1.45% |
| 7 | ADPT | Adaptive Biotechnologies | 1.39% |
| 8 | XMTR | Xometry | 1.25% |
| 9 | FEIM | Frequency Electronics | 1.24% |
| 10 | NBN | Northeast Bank | 1.03% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0354 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0053 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0100 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0524 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0731 |
| Sep 23, 2024 | Sep 27, 2024 | $0.51 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0821 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0488 |
| Dec 18, 2023 | Dec 22, 2023 | $0.83 |
| Sep 18, 2023 | Sep 22, 2023 | $0.12 |
| Jun 20, 2023 | Jun 23, 2023 | $0.18 |
| Mar 20, 2023 | Mar 24, 2023 | $0.0547 |